In the CSF, OCR-treated PP-MS exhibited a significant depletion of CCR5+, CXCR3+, CCR6+, and CCR4+ CD4+CD20+ memory T cells, suggesting a relation with the reduced proportion of their blood counterparts, but not in the CD8+ memory T cell pool [33]. The gene discussed is MS4A1; the disease is myeloid sarcoma.